NORTHERN TRUST CORP - TALIS BIOMEDICAL CORP ownership

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$13,373
-2.0%
27,8600.0%0.00%
Q1 2023$13,652
+9.9%
27,8600.0%0.00%
Q4 2022$12,417
-34.6%
27,8600.0%0.00%
Q3 2022$19,000
-13.6%
27,8600.0%0.00%
Q2 2022$22,000
-87.4%
27,860
-77.5%
0.00%
Q1 2022$175,000
-65.8%
123,761
-3.0%
0.00%
Q4 2021$511,000
-37.5%
127,628
-2.3%
0.00%
Q3 2021$817,000
-46.7%
130,617
-5.9%
0.00%
Q2 2021$1,532,000
-13.9%
138,812
+0.2%
0.00%
Q1 2021$1,779,000138,4810.00%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,073,1760.05%
WELLS FARGO & COMPANY/MN 174$840.00%
NORTHERN TRUST CORP 27,860$13,3730.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 140,530$67,4540.00%
STATE STREET CORP 47,436$22,7690.00%
MILLENNIUM MANAGEMENT LLC 91,463$43,9020.00%
DEUTSCHE BANK AG\ 45,294$21,7410.00%
MORGAN STANLEY 61,857$29,6910.00%
BlackRock Inc. 76,307$36,6280.00%
View complete list of TALIS BIOMEDICAL CORP shareholders